Barclays’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-50
| Closed | – | – | 7838 |
|
|
2018
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 7731 |
|
|
2018
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 7672 |
|
|
2018
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 7684 |
|
|
2017
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 7410 |
|
|
2017
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 7353 |
|
|
2017
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 7308 |
|
|
2017
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 7302 |
|
|
2016
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 7160 |
|
|
2016
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 7125 |
|
|
2016
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 7037 |
|
|
2016
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 6912 |
|
|
2015
Q4 | $0 | Buy |
+50
| New | +$826 | ﹤0.01% | 7322 |
|
|
2014
Q4 | – | Sell |
-414
| Closed | – | – | 8052 |
|
|
2014
Q3 | $0 | Sell |
414
-3
| -0.7% | -$116 | ﹤0.01% | 8132 |
|
|
2014
Q2 | $17K | Hold |
417
| – | – | ﹤0.01% | 6608 |
|
|
2014
Q1 | $17K | Hold |
417
| – | – | ﹤0.01% | 6697 |
|
|
2013
Q4 | $0 | Hold |
417
| – | – | ﹤0.01% | 8036 |
|
|
2013
Q3 | $33K | Sell |
417
-4,122
| -91% | -$453K | ﹤0.01% | 6297 |
|
|
2013
Q2 | $352K | Buy |
+4,539
| New | +$435K | ﹤0.01% | 4621 |
|